National Immunogenicity & Biologics Evaluation Center

Question:Consider the following with respect to National Immunogenicity & Biologics Evaluation Center:
(1) It is a first of its kind centre in the country developed for evaluation of the immunogenicity of vaccines & antiviral properties of drugs/preparations.
(2) It has been established jointly by Bharati Vidyapeeth University and BIRAC-DBT.
Which is/are correct?
(a) 1 only
(b) 2 only
(c) Both 1 and 2
(d) None of these
Answer:(c)

  • Context:
  • Department of Biotechnology(DBT) Secretary has inaugurated National Immunogenicity & Biologics Evaluation Center(NIBEC).
  • Facts:
  • About NIBEC: It is a first of its kind centre in the country developed for evaluation of the immunogenicity of vaccines & antiviral properties of drugs/preparations.
  • Developed by: It has been established jointly by Bharati Vidyapeeth University through its constituent unit Interactive Research School for Health Affairs(IRSHA) and BIRAC-DBT through National Biopharma Mission.
  • Additional Facts:
  • National Biopharma Mission(NBM):
  • It is an industry-academia collaborative mission for accelerating biopharmaceutical development in the country.
  • Launched Year: It was launched in 2017 at a total cost of Rs 1500 crore and is 50% co-funded by World Bank loan.
  • Implementation: Biotechnology Industry Research Assistance Council (BIRAC).
  • Innovate in India(i3) programme: It has been launched under this mission to create an enabling ecosystem to promote entrepreneurship and indigenous manufacturing in the biopharma sector.
  • BIRAC:
  • It is a not-for-profit state owned enterprise under the Department of Biotechnology (DBT) to strategically empower emerging biotech companies.

By:Arpit Mishra

Link:

https://pib.gov.in/PressReleasePage.aspx?PRID=1651639